Evidence map›Paper›PMID 40512008›Full record

ReviewInfection and immunity2025

Working together: gut microbe-microbe interactions shape host inflammation.

Ally Lawing, Rachel Bleich

Abstract readReview
In one paragraph

Review in Infection and immunity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Expansion resistance against genotoxicFrontiers in microbiology · 2026
    Article
  4. Recent advances in the positive role ofFrontiers in immunology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ally LawingDepartment of Biology, Appalachian State University, Boone, North Carolina, USA.
Rachel BleichDepartment of Biology, Appalachian State University, Boone, North Carolina, USA.ORCID 0000-0002-8170-483X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) is a debilitating disorder characterized by chronic intestinal inflammation that currently has no cure. Alterations to the composition of the gut microbiota, including reduced microbial diversity and expansion of pathobionts like Enterobacteriaceae, are implicated in IBD. While this dysbiosis has been well-documented, our understanding of the function of these microbes in the development and progression of IBD is more limited. As part of the gut microbiota, these microbes undergo complex interactions with many other microorganisms that impact the structure and function of the microbial community and the health of the host. These include competitive interactions for nutrients and space and cooperative interactions that help optimize resource utilization and microbial fitness. In this minireview, we discuss the microbe-microbe interactions that can impact host inflammation and IBD progression and treatment. Due to their association with IBD, we put special emphasis on interactions between Enterobacteriaceae and other members of the microbiota that are competitive, commensal, and mutualistic. To better understand these interactions, the signals that mediate microbial interactions are highlighted, including contact-dependent and contact-independent mechanisms. Finally, mucosal biofilms involving pathobionts are examined due to their proximity to the host and ability to influence inflammation.

Indexed as

Gastrointestinal MicrobiomeHost-Pathogen InteractionsInflammationInflammatory Bowel DiseasesMicrobial InteractionsAnimalsBiofilmsDysbiosisEnterobacteriaceaeHost Microbial InteractionsHumansinflammationmicrobe-microbe interactionspolymicrobial interactions

Identifiers

PMID40512008
PMCPMC12234441

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.